Herpes zoster vaccine (HZV): utilization and coverage 2009 – 2013, Alberta, Canada

BACKGROUND: Herpes zoster vaccine (HZV) is not publicly funded in the province of Alberta, Canada. We estimated vaccine coverage among those aged 60 years or older for 2013, as well as vaccine utilization rates per hundred thousand population over the period 2009 – 2013. We explored for factors asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xianfang C, Simmonds, Kimberley A, Russell, Margaret L, Svenson, Lawrence W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287544/
https://www.ncbi.nlm.nih.gov/pubmed/25342438
http://dx.doi.org/10.1186/1471-2458-14-1098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287544/
https://www.ncbi.nlm.nih.gov/pubmed/25342438
http://dx.doi.org/10.1186/1471-2458-14-1098

Ejemplares similares